WO2021168022A1 - Interferential treatment with modified beat frequency - Google Patents
Interferential treatment with modified beat frequency Download PDFInfo
- Publication number
- WO2021168022A1 WO2021168022A1 PCT/US2021/018438 US2021018438W WO2021168022A1 WO 2021168022 A1 WO2021168022 A1 WO 2021168022A1 US 2021018438 W US2021018438 W US 2021018438W WO 2021168022 A1 WO2021168022 A1 WO 2021168022A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- range
- beat
- indicator
- beat frequencies
- nervous system
- Prior art date
Links
- 230000035559 beat frequency Effects 0.000 title claims abstract description 92
- 238000011282 treatment Methods 0.000 title claims abstract description 73
- 230000000694 effects Effects 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 26
- 210000003403 autonomic nervous system Anatomy 0.000 claims abstract description 25
- 230000004044 response Effects 0.000 claims description 48
- 230000002567 autonomic effect Effects 0.000 claims description 3
- 210000003414 extremity Anatomy 0.000 claims description 3
- 210000003141 lower extremity Anatomy 0.000 claims 1
- 210000001364 upper extremity Anatomy 0.000 claims 1
- 238000013459 approach Methods 0.000 description 14
- 230000008901 benefit Effects 0.000 description 9
- 210000003127 knee Anatomy 0.000 description 7
- 238000004891 communication Methods 0.000 description 6
- 230000003906 autonomic nervous system functioning Effects 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 230000000712 assembly Effects 0.000 description 4
- 238000000429 assembly Methods 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 238000011269 treatment regimen Methods 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 210000001747 pupil Anatomy 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 238000002847 impedance measurement Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 241000282860 Procaviidae Species 0.000 description 1
- 241000024109 Spiris Species 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 210000001590 sural nerve Anatomy 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000001137 tarsal bone Anatomy 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36031—Control systems using physiological parameters for adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0531—Measuring skin impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/294—Bioelectric electrodes therefor specially adapted for particular uses for nerve conduction study [NCS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4035—Evaluating the autonomic nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0484—Garment electrodes worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/323—Interference currents, i.e. treatment by several currents summed in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/388—Nerve conduction study, e.g. detecting action potential of peripheral nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/6804—Garments; Clothes
Definitions
- Interferential treatment which Is described in some detail in U.S. Patents 5,995,873; 6,826,429; 8,515,551; 9,061,145 and 9,333,348, the disclosures of which are incorporated herein by reference.
- the basic approach is to apply electrodes at various places on the human body and deliver pulses of electricity through the electrodes.
- Two, three or four pairs of electrodes are typically used In an interferential treatment. Each electrode is placed adjacent a nerve ending, an acupuncture point or a reflexology point of the patient, often on a foot or hand,
- the interferential, treatment includes delivering a carrier frequency and a beat frequency through the electrodes.
- interferential treatments comprise applying beats or pulses, however produced.
- the effectiveness of the interferential treatment is measured in a suitable .manner.
- One simple effective approach to measure short term success is to measure the temperature of the patient's hand, foot or digits. Increased measured temperature is a proxy for increased blood circulation which is related to the effectiveness of the interferential technique.
- the measure of long terra success is, of course, relief -from pain or the ailment suffered by the patient Long term success is the goal but, to get there, short term success conies first,
- the problem is to select a combination of electrode placement and beat frequency that delivers an effective treatment. There are tens of thousands of combinations of electrode placements and beat frequencies to use in an electrical interferential treatment regimen. Invariably some combination of electrode placement and beat frequency are better than other combinations.
- Experimentation is necessary to determine workable electrode placements and beat frequencies because the measured response varies from patient-to-patlent and from time-to- time with the same patient, if a combination of electrode placement and one range of beat frequencies does not achieve an increased temperature response, the electrode placement is changed or the range of beat frequencies is changed. This process is repeated until a satisfactory response is obtained.
- the selection of an acceptable combination of electrode pattern and beat frequency is complicated by the vast multitude of electrode placements and beat frequencies plus the production of inconsistent selections and inconsistent patient response to the same selection of electrode placement and beat frequency.
- the disclosed technique involves adjusting the beat frequency selection in response to another parameter which varies in a manner differently than a normally used parameter which is a proxy for the effectiveness of an electrical interferential treatment regimen.
- the normally used parameter may be skin temperature which is a proxy for increased blood circulation which is one measure of the effectiveness of an interferential treatment regimen.
- the other parameter may be skin impedance or any other indicator of autonomic system activity. Skin impedance is measured in any suitable manner » such as disclosed in an article entitled ”Skin Impedance Measurements Using Simple and Compound Electrodes,” Med. & Bio. Eng. & Coinput., 1992 P97-1G2 by EJ. Woo et al
- the beat frequency is narrowed using measurements of skin impedance as a guide.
- the range of beat frequencies is 1-10 and a small positive temperature increase is noted, for example one half degree F
- the range may be narrowed to 4-8 beats applied to the patient to determine whether skin impedance increases from the previous selection, in one sense, the narrowed range of beat frequencies lies wholly within the first range but, in other sense, the narrower range of frequencies overlays the first, range.
- the beat frequency range may be narrowed to 5-6 beats and the process repeated to determine its effectiveness.
- Electrodes When trials or treatments are conducted by the patient or a relatively untrained caregiver, the placement of electrodes is often haphazard so it may be desirable to provide ⁇ a guide or template that can be used to place electrodes properly. This can be accomplished by a garment worn by the patient having indicia designating die desired electrode location. Because there are many potential electrode sites, many different garments may be provided or many different patterns may be employed to transfer the desired electrode placement to a garment
- a farther object of this invention is to provide an approach tor narrowing the beat frequency selection by incorporating inputs from more than one indicator of autonomic nervous system activity.
- Another object of this invention is to provide a guide or template for placing electrodes correctly.
- a more specific object of this Invention is to provide a garment having indicia applied to the garment to indicate the location to place electrodes,
- a further object of this invention is to provide a method and apparatus for treating a sleeping patient
- Figure 1 is a schematic view of an interferential treatment device deployed on a patient
- Figure 2a is a graph of skin impedance over time showing an improved interferential response
- Figure 2b is a graph of skin impedance over time showing no improvement in response to an interferential treatment
- Figure 3 is a front view of a pair of pants having indicia thereon indicating one preferred electrode location;
- Figure 4 is a partial back view of the pants of figure 3;
- Figure 5 is a photograph of another garment useful as a guide for electrode placement
- Figure 6 is a back vie w of the knee brace sho wn in Figure 5 illustrating the knee brace on a patient and illustrating the sites where electrodes are to be placed in one common electrode pattern;
- Figure 7 is a front view, similar to Figure 6. illustrating the sites where electrodes are to be placed in one common electrode pattern
- Figure 8 is a view of a device to conduct interferential trials and interferential treatments while a patient sleeps; and Figure 9 is a schematic view of an electrode assembly of Figure 8.
- a patient 10 is booked up to an electrical interferential therapy device 12 inside a housing 14.
- the electrical interferential therapy device 12 may include a more-or-less conventional treatment module 16 such as is commercially available from Alan Neuroniedical Technologies LLC of The Woodlands, Texas to which reference is made for a more complete description thereof.
- a wide variety of parameters may be used to monitor the autonomic nervous system and thereby determine the effect of an interferential treatment on the patient. These parameters may include skin impedance or resistivity, peripheral skin temperature, pulse rate, blood pressure, iris
- one or more sensors 18, 20 which may preferably be a digital temperature sensor incorporated into a spring biased clip which may attach to a .finger or toe on either or both sides of the patient 10.
- the sensors 18, 20 may connect by a wire 22, 24 to a module 28 in the housing 14.
- the module 28 may be a data processor to record the temperature sensings from the sensors 18, 20, store the values in a memory module 30, control fee treatment module 16, otherwise operate fee device 12 and may transmit any data, stored or unstored, to a suitable storage location such as the cloud.
- Other sensors are equally effective and under some conditions, more so.
- a temperature sensor sewn into a garment would be particularly desirable when the patient is undergoing treatment when, asleep or conducting
- wire or braided wire embedded or woven into a garment would be suitable.
- the housing 14 may include a series of receptacles 32, 33, 34 35 capable of accepting a jack 36, 37, 38, 39 of insulated wire pairs 40, 41, 42, 43 leading to electrode pairs 44, 44345, 45', 46, 46', 47, 47.
- a suitable display 48 provides readings such as values from the sensors 18,
- the device 12 may be battery powered which can allow treatment while the patient sleeps or by wearing foe unit during foe- day.
- Standard commercially available electrical interferential treatment devices have either a fixed carrier frequency or a minimally selectively variable carrier frequency. For reasons which are mainly historical, these frequencies are convenrionaljy 1850 Hz and 2850 Hz in the Sympathetic Therapy System from Dynatronics, Inc. or 4000 Hz in a device commercially available from Rehabilicare Corporation of St. Paul, Minnesota,
- the device 12 may include a select actuator 50 and ap/down actuators 52, 54.
- intensity can only be set at the beginning of a treatment.
- An advantage of foe current approach is foe data processor module 28 can change the intensity of the pulses delivered through the electrodes in foe middle of a treatment regimen m response to foe number of number
- the module 2B may provide other functions.
- the electrodes 44, 44 5 , 46, 46' don't provide good sensings indefinitely.
- the module 28 may run tests to determine whether the electrodes need to be replaced, may count the number of treatments or the number of parameter determining trials are run and display a message on the screen 48 to replace the electrodes, in response to such a message, the select actuator 50 may be depressed to send a message to the module 28 that the electrodes have been or will be changed.
- the device 12 may also include a timer function and the time of and duration of treatments and/or the acquisition of treatment parameters.
- the device 12 may also include an on ⁇ off switch 56, The device 12 may preferably be battery powered thereby enabling the patient to undergo treatment when asleep and, if the device 12 is small enough, to undergo treatment while walking, driving or In the conduct of normal daily activities.
- the carrier and beat frequencies used in selecting treatment parameters may be selected by the actuators SO, 52, 54 or default selections may he provided by software in the processor 28.
- the vast majority of desirable beat frequencies are between 1-150 beats per second (bps) although current commercially available devices only employ 1-80 beats per second. In attempts to find an effective beat frequency in a reasonable time frame, this range has been subdivided into segnents of a small fraction of 1-150 Hz, typically 1-10 bps, 11-20 bps, 21 -30 bps, 31 -40 bps etc.
- the increase actuator 52 When it is desired to increase die treatment intensity, the increase actuator 52 is depressed a t the outset of a treatment or in response to the processor module 28 daring a treatment as discussed above * It will accordingly be seen that the device 12 includes a circuit for delivering therapeutic electrical energy into the body of the patient and more particularly includes a subcircuit for modifying the carrier frequency, the beat frequency and/or the amplitude of alternating current type energy.
- the electrodes are attached to the patient's skin or to a garment as explained hereinafter, he. they may be self adherent.
- the location of the electrodes on the patient establishes the electrical circuit in the patient's body.
- one electrode 44 is placed adjacent the end or terminus of the right media! planar nerve L5 and. its matching electrode or mate 44* is placed adjacent the end or terminus of the left sural nerve SI, inferior to the left ankle bone (lateral malleolus) thereby establishing a first electrical circuit in the patient's body.
- L5, S 1 and the like are standard medical terminology for nerves in the human leg.
- the electrode pattern in Figure 1 is shown in U .S.
- Patent 5,995,873 to which reference is made for a more complete description, It will be understood there are hundreds or thousands of potential electrode patterns using different number of electrode pairs.
- a preferred approach may be to use an additional four electrodes for a total of eight
- the addi tional electrodes may be placed in any suitable manner, such as in an L-4, S2, L5-L4 patern.
- Those skilled in the art will recognize this description as representative of commercially available electrical interferential treatment devices available ftom Alan Neuromediea! Technologies LLC of The Woodlands, Texas. in order to adjust the selection of the beat frequency, two of the indicators of autonomic- nervous system activity are used together.
- skin impedance or resistance may be used as a secondary indicator to modify the beat selection by adjusting the beat selection from one range to a narrower or wider range or to a single number.
- skin impedance or resistance may be used as a secondary indicator to modify the beat selection by adjusting the beat selection from one range to a narrower or wider range or to a single number.
- skin impedance or resistance may be used as a secondary indicator to modify the beat selection by adjusting the beat selection from one range to a narrower or wider range or to a single number.
- skin impedance or resistance may be used as a secondary indicator to modify the beat selection by adjusting the beat selection from one range to a narrower or wider range or to a single number.
- the beat frequency may be narrowed in response to readings from a skin impedance or resistance sensor 58 connected by a wire or communication link 60 to the unit 12.
- the impedance sensor 58 may preferably be near one paid of the electrodes, for example on the same hand, foot or limb. Over time, the response to interferential treatment as measured by skin temperature backs theresponse as measured byskin impedance.
- An advantage of using skin impedance is that changes in skin impedance occur and can be measured in a matter of seconds while changes in skin temperature occur and can be measured in a matter of minutes.
- skin impedance Increases in the short term, and will he verified several minutes later by skin temperature rises. This process of narrowing the range of beat frequencies may be repeated to again modify the skin temperature response.
- a first narrowed range may be 2-8 beats/second
- a second narrowed range may be 4-6 beats/second
- a third narrowed range may be 4,5-5.5 beats/second.
- the situation in electrical Interferential treatment is to find a combination of electrode placement and beat frequency that produces an adequate temperature response, in the past, this has typically been done by changing the electrode placement or by changing from beat selection from a default range of 1-10 to ranges of 11-20, 21-30 and so on.
- the idea is to find a temperature response that may be inadequate and then attempt to fine tune fee beat frequency in response to another parameter such as skin resistivity or impedance.
- impedance is defined either as resistance, Impedance or resistance and impedance.
- the current standard pattern for 11-20 beats/second is 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11 and then repeat Similarly, the restricted beat frequency range may be in any suitable pattern, e.g.4, 5, 6, 7, 7, 6, 5, 4, if results from the sensor 58 dictates a
- peripheral skin temperature and skin impedance or resistivity has the advantage of low cost, reliable relatively unambiguous peripheral skin temperature and low cost, rapid response of skin impedance or resistivity.
- Other combinations of parameters arc operable and have their advantages because they have different, responses to the same interferential treatment, different response times, different costs, different difficulties of use and other differences.
- Figure 2a shows a graph of skin impedance versus time showing an initial short term, decrease in skin impedance followed by a longer term response where skin impedance increases. This type response typically shows an improved .response to interferential treatment.
- Figure 2b shows a graph of skin impedance versus time showing no change in skin impedance and consequently no change in response to interferential treatment.
- the time interval expressed in Figure 2a is usually on the order of less than one minute.
- the sites 66 may be applied to the garment, fabric 64 in any suitable manner.
- the pattern of electrodes is a common effective eight electrode pattern. This illustrated pattern is exemplary only and many different patterns using different numbers of electrodes are feasible.
- the electrodes 44, 44’, 46, 46' ’ may be applied directly to the fabric 64 of the garment 62 or the locations 66 may comprise a hole in the iltbric 64 but coded around the hole as will he apparent hereinafter so the electrodes may be applied directly to the patient's skin.
- the electrode pattern on the garment 62 Is conveniently illustrated to be coded so indicia 68 at the site 66 corresponds to a similar number on the electrode or electrode wire shown in Figure I .
- Any suitable technique may be used, Referring to Figures 5-7, there is illustrated one commonly used electrode pattern incorporated into a knee brace 70 providing another example of a garment which may be used to locate electrodes in an appropriate location.
- the knee brace 70 includes an opening 72 which is placed over the kneecap of the wearer and thereby position the brace in repeatable positions.
- the electrodes 74, 76, 78 may be sewn into the brace 70 on the front of the knee brace and electrodes 80, 82 may be sewn on the back and suitable wires or communication links (not shown) provided connecting the electrodes to the module 28.
- indicia may be provided on the brace 70 to Indicate an electrode placement
- Similar VELCRO wraps may be used on the hand, using the thumb as an anatomical landmark, or may he used on the foot and ankle using the ankle bones as an anatomical landmark io position the wrap correctly.
- the electrode pattern on the knee brace 70 is conveniently illustrated to be coded so Indicia.
- 84 at the electrode sites correspond to a similar number on the electrode or electrode wire shown in Figure 1. Any suitable technique may he used.
- FIG. 8-9 there is illustrated another electrical interferential system 86 that looks much different than Figure 1 but which operates similarly.
- the system 86 Includes a control module 88 which may be placed on a bedside table of the patient and one or more bodily worn garments 90,
- the control module 8S may be battery powered or conventionally powered through household electrical connections.
- Some of the bodily worn garments may he such as shown hi Figures 3-7 to which electrode assemblies 92 are attached at the designated locations and to which is attached a suitable primary sensor 94 such as a skin thermometer and a suitable secondary sensor 96 such as a skin impedance sensor.
- the bodily worn garments may include a pair of gloves or wrist hands 98 to which are attached electrode assemblies 100 and a primary sensor 192 and may include a secondary sensor 104 such as a skin impedance sensor.
- the control module 88 and the garments 90, 98 may include a wireless communication system 106 so the control module 88 can send wireless signals to the electrode assemblies 90, 98 and receive information from the sensors 94, 96, 102, 1.04.
- the system 86 includes a communication system 108 communicating with a receiver so the data recovered from the sensors 94, 96, 102, 104 and other suitable information can be saved tor later viewing by the patient or medical personnel, Currently, the cloud may be a preferred location for data storage but this depends on future developments,
- An exemplary electrode assembly 92 is shown in more detail in Figure 9 and includes a circuit 110 including a battery 112, a wireless operated on-off switch 114, a beat generator 116 delivering pulses to an electrode 1.18 in communication with the skin of the patient and a short distance communication device 120.
- the circuit 110 also includes a primary sensor 122 for detecting a response of the autonomic nervous system and a secondary sensor 124 for adjusting the range of beat frequencies in response to a secondary indicator of autonomic system response.
- the primary sensor 122 may be a skin temperature sensor and the secondary sensor 124 may be a skin impedance sensor.
- the control module 88 adjusts the range of beat frequencies applied by the electrodes 118 in response to information from the secondary sensor 124.
- An important advantage of the system of Figures 8-9 is the ability to treat the patient while asleep. Not only does this allow for longer treatment times but also allows for the application of different treatments. It may he preferred that a lower body garment is placed on the knees or feet of the patient and m upper body garment 90, 98 placed on the hands or wrists of the patient. A lower body treatment would be followed by an upper body treatment The
- 17 module 88 would t hen turn off the electrode assemblies 92, 100 and after a suitable wait, repeat the upper and lower body treatments.
- Lower and upper body treatments tend to create more of one neuropeptide and less of another. When combined, the lower and upper body treatments combine to overcome the deficiencies of each other and make a good combination.
- One approach that may be preferred is to conduct upper and lower body treatments when the patient is asleep, thereby affording time for multiple approaches-
- One approach is to conduct an upper and a lower body treatment followed by a delay of several hours and then conduct another upper and lower body treatment
- Another approach is to conduct a trial in the middle of a treatment by again adjusting the beat frequency and determining whether the response from the primary and/or secondary’ sensors shows an improvement
- Operation of the system 86 commences when the patient has placed the garments 90, 98 in their appropriate locations so the electrodes are located at their desired sites.
- the control module 88 is turned on and includes some mechanism to determine whether the patient is asleep, This may be simply a tinier, may be a more sophisticated head attached device used In sleep clinics or may be something intermediate such as a motion sensor equipped with soft ware to realize the patient isn’t moving much.
- the system 86 Is turned on and the sleep recognizer detects when the patient is asleep.
- the module 88 then signals the beat generators 116 to deliver a range of heat frequencies to the electrodes 118, detects responses from the sensors 122, 124 and adjusts the range of beat frequencies accordingly-
- the analogous fingers of the left and right hands show a temperature variation of less than IT no matter what the ambient temperature is.
- the hand that is colder is usually due to the prevalence of norepinephrine which diminishes the circulation in the cold hand. Interferential treatments often normalize the leif/sight differentia! and demonstrate an improvement in the patient.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Electrotherapy Devices (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Transplanting Machines (AREA)
- Developing Agents For Electrophotography (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021224165A AU2021224165A1 (en) | 2020-02-20 | 2021-02-18 | Interferential treatment with modified beat frequency |
MX2022010197A MX2022010197A (en) | 2020-02-20 | 2021-02-18 | Interferential treatment with modified beat frequency. |
JP2022549599A JP2023523673A (en) | 2020-02-20 | 2021-02-18 | Interferometric therapy to modify beat selection |
CA3171875A CA3171875A1 (en) | 2020-02-20 | 2021-02-18 | Interferential treatment with modified beat selection |
EP21756971.4A EP4106860A4 (en) | 2020-02-20 | 2021-02-18 | Interferential treatment with modified beat frequency |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062979350P | 2020-02-20 | 2020-02-20 | |
US62/979,350 | 2020-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021168022A1 true WO2021168022A1 (en) | 2021-08-26 |
Family
ID=77367089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/018438 WO2021168022A1 (en) | 2020-02-20 | 2021-02-18 | Interferential treatment with modified beat frequency |
Country Status (7)
Country | Link |
---|---|
US (1) | US11517753B2 (en) |
EP (1) | EP4106860A4 (en) |
JP (1) | JP2023523673A (en) |
AU (1) | AU2021224165A1 (en) |
CA (1) | CA3171875A1 (en) |
MX (1) | MX2022010197A (en) |
WO (1) | WO2021168022A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050278001A1 (en) * | 2004-06-15 | 2005-12-15 | Li Qin | Interferential and neuromuscular electrical stimulation system and apparatus |
US20060030906A1 (en) * | 2004-08-06 | 2006-02-09 | Carroll William J | Switchable and programmable electrode configuration |
US20150297888A1 (en) * | 2012-09-17 | 2015-10-22 | Donald Alan Rhodes | Apparatus for determining optimum treatment parameters |
US20170266443A1 (en) * | 2006-10-02 | 2017-09-21 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US20190143097A1 (en) * | 2017-11-16 | 2019-05-16 | Ebt Medical, Inc. | Percutaneous and transcutaneous peripheral neuromodulation |
US10485977B1 (en) * | 2018-06-28 | 2019-11-26 | Feinstein Patents, Llc | System and method employing interferential electrical stimulation to treat cardiac issues |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5540736A (en) | 1993-08-02 | 1996-07-30 | Haimovich; Yechiel | Transcranial electrostimulation apparatus having two electrode pairs and independent current generators |
US5995873A (en) | 1998-07-07 | 1999-11-30 | Rhodes; Donald A. | Treatment of pain and of the nervous system |
US6826429B2 (en) | 2001-01-19 | 2004-11-30 | Dynatronics Corporation | Interferential current treatment apparatus |
US20070219598A1 (en) * | 2006-03-14 | 2007-09-20 | Rhodes Donald A | Diagnostic method and apparatus |
US8515551B2 (en) * | 2006-03-14 | 2013-08-20 | Donald A. Rhodes | Diagnostic method and apparatus |
US20070298895A1 (en) | 2006-06-21 | 2007-12-27 | Nusbaum Mark E | Golf swing analyzing/training mat system with ball striking-related feedback |
US11338120B2 (en) * | 2012-08-29 | 2022-05-24 | Palo Alto Investors LP | Methods and devices for treating parasympathetic bias mediated conditions |
US11759389B2 (en) | 2013-12-31 | 2023-09-19 | Iftech Inventing Future Technology, Inc. | Wearable devices, systems, methods and architectures for sensory stimulation and manipulation and physiological data acquisition |
WO2015187712A1 (en) | 2014-06-02 | 2015-12-10 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
KR102612964B1 (en) * | 2015-02-15 | 2023-12-13 | 지브 헬스케어 엘티디. | Systems and methods for improving heart rate variability |
EP3565631B1 (en) | 2017-01-05 | 2024-04-24 | Noctrix Health, Inc. | Restless leg syndrome or overactive nerve treatment |
US10493272B1 (en) | 2018-06-01 | 2019-12-03 | Feinstein Patents, Llc | Inferential electrical stimulation device with targeting capabilities |
US10456573B1 (en) | 2018-06-18 | 2019-10-29 | Feinstein Patents, Llc | Medical cuff employing electrical stimulation to control blood flow |
EP3813647A4 (en) | 2018-06-27 | 2022-03-09 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
US20220183925A1 (en) | 2019-03-08 | 2022-06-16 | Kim H. Manwaring | A device and method to induce interferential beat vibrations and frequencies into the body |
US10682512B1 (en) | 2019-06-28 | 2020-06-16 | Feinstein Patents, Llc | System and method employing interferential electrical stimulation following surgery |
-
2021
- 2021-02-15 US US17/175,794 patent/US11517753B2/en active Active
- 2021-02-18 EP EP21756971.4A patent/EP4106860A4/en active Pending
- 2021-02-18 AU AU2021224165A patent/AU2021224165A1/en active Pending
- 2021-02-18 WO PCT/US2021/018438 patent/WO2021168022A1/en unknown
- 2021-02-18 JP JP2022549599A patent/JP2023523673A/en active Pending
- 2021-02-18 CA CA3171875A patent/CA3171875A1/en active Pending
- 2021-02-18 MX MX2022010197A patent/MX2022010197A/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050278001A1 (en) * | 2004-06-15 | 2005-12-15 | Li Qin | Interferential and neuromuscular electrical stimulation system and apparatus |
US20060030906A1 (en) * | 2004-08-06 | 2006-02-09 | Carroll William J | Switchable and programmable electrode configuration |
US20170266443A1 (en) * | 2006-10-02 | 2017-09-21 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US20150297888A1 (en) * | 2012-09-17 | 2015-10-22 | Donald Alan Rhodes | Apparatus for determining optimum treatment parameters |
US20190143097A1 (en) * | 2017-11-16 | 2019-05-16 | Ebt Medical, Inc. | Percutaneous and transcutaneous peripheral neuromodulation |
US10485977B1 (en) * | 2018-06-28 | 2019-11-26 | Feinstein Patents, Llc | System and method employing interferential electrical stimulation to treat cardiac issues |
Non-Patent Citations (1)
Title |
---|
See also references of EP4106860A4 * |
Also Published As
Publication number | Publication date |
---|---|
US11517753B2 (en) | 2022-12-06 |
EP4106860A4 (en) | 2024-03-20 |
JP2023523673A (en) | 2023-06-07 |
US20210260376A1 (en) | 2021-08-26 |
MX2022010197A (en) | 2023-01-04 |
AU2021224165A1 (en) | 2022-10-06 |
EP4106860A1 (en) | 2022-12-28 |
CA3171875A1 (en) | 2021-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7470160B2 (en) | Systems and methods for treating cardiac dysfunction via peripheral nerve stimulation - Patents.com | |
US20240206743A1 (en) | System for management and prevention of venous pooling | |
US20220266012A1 (en) | Systems, methods and devices for peripheral neuromodulation | |
EP2097056B1 (en) | Electrotherapeutic device | |
ES2928639T3 (en) | Systems and methods of patient therapy | |
US8515551B2 (en) | Diagnostic method and apparatus | |
WO2020006048A1 (en) | Multi-modal stimulation for treating tremor | |
US20080119896A1 (en) | Method and device for anti-sleep apnea | |
US20070219598A1 (en) | Diagnostic method and apparatus | |
US20220331582A1 (en) | Acupoint stimulation device and acupoint stimulation method using the same | |
JP2011045562A (en) | Low frequency pulse applying device and method of using the same | |
US11517753B2 (en) | Interferential treatment with modified beat frequency | |
KR200458596Y1 (en) | Smart medical glove system | |
KR20210090909A (en) | Apparatus for sleep management using device of stimulating acupoint and method for sleep management using it | |
KR20210090910A (en) | Apparatus for controlling blood pressure using device of stimulating acupoint and method for controlling blood pressure using it | |
JP2020528797A (en) | Patient treatment system and method | |
GB2619011A (en) | Apparatus and method for causing vasoconstriction by electrical stimulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21756971 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022549599 Country of ref document: JP Kind code of ref document: A Ref document number: 3171875 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021756971 Country of ref document: EP Effective date: 20220920 |
|
ENP | Entry into the national phase |
Ref document number: 2021224165 Country of ref document: AU Date of ref document: 20210218 Kind code of ref document: A |